Generate Biomedicines, Inc. (GENB)

Generate Biomedicines will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Generate Biomedicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.11	-0.11	-0.18
Debt / EBITDA Ratio	-0.30	-0.30	-0.41
Debt / FCF Ratio	-0.34	-0.34	-0.64
Quick Ratio	2.70	2.70	4.56
Return on Equity (ROE)	36.20%	36.20%	41.74%
Return on Assets (ROA)	-67.53%	-67.53%	-35.00%
Return on Capital Employed (ROCE)	-94.90%	-94.90%	-45.68%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).